Trial Profile
Effect of Anti-IgE in Chronic Urticaria
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Urticaria
- Focus Adverse reactions; Therapeutic Use
- 21 Oct 2014 New trial record